Top Markets
Coin of the day
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.

ZIOPHARM Oncology, Inc.

ZIOP
Κατάταξη σε μετοχές #20771
ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to... ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing innovative immuno-oncology treatments for cancer patients. The company leverages its proprietary Sleeping Beauty platform, which employs non-viral genetic engineering to modify T-cells outside the body using a transposon/transposase system for subsequent infusion. Additionally, ZIOPHARM is advancing its Controlled IL-12 technology, designed to precisely regulate the expression of interleukin-12 (IL-12), a key immune system regulator, to direct the patient's immune response against cancer cells. Its pipeline features several promising therapeutic candidates, including T-cell receptor (TCR) plus T-cell therapies aimed at solid tumors, chimeric antigen receptor (CAR) T-cell therapies specifically targeting CD19 for hematologic malignancies, and Ad-RTS-hIL-12 combined with veledimex, a gene delivery system for controlled IL-12 production under investigation for treating recurrent adult glioblastoma multiforme. ZIOPHARM maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., and research and development agreements, alongside patent licensing, with institutions such as The University of Texas MD Anderson Cancer Center and the National Cancer Institute. The company's headquarters are located in Boston, Massachusetts.
Τιμή μετοχής
$0.8657
Τελευταίος συγχρονισμός: 2022-01-26
Κεφαλαιοποίηση
$122.22M
Αλλαγή (1 ημέρα)
-0.88%
Αλλαγή (1 έτος)
0.00%
Χώρα
US
Εμπόριο ZIOPHARM Oncology, Inc. (ZIOP)

Κατηγορία

Ιστορικό τιμής μετοχής για την ZIOPHARM Oncology, Inc. (ZIOP)
Υψηλότερη τιμή κλεισίματος: $0.95 στις 2022-01-01

Χαμηλότερη τιμή κλεισίματος: $5.02 στις 2006-09-01
Ιστορικό τιμής μετοχής της ZIOPHARM Oncology, Inc. από 2006 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2022 -23.02%
2021 -56.03%
2020 -44.13%
2019 97.81%
2018 -40.03%
2017 -31.39%
2016 -34.33%
2015 115.72%
2014 7.85%
2013 -2.45%
2012 -8.50%
2011 -1.08%
2010 50.36%
2009 290.84%
2008 -73.45%
2007 -52.27%
2006 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.14 -15.28%
AU
$770.19 8.98%
CH